Testing effectiveness (Phase 2)Study completedNCT01283542
What this trial is testing
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
Who this might be right for
Non-functioning Pituitary Adenoma
Novartis Pharmaceuticals 20